A blog from the Centre for Research Ethics & Bioethics (CRB)

Month: April 2022

How can we detect consciousness in brain-damaged patients?

Detecting consciousness in brain-damaged patients can be a huge challenge and the results are often uncertain or misinterpreted. In a previous post on this blog I described six indicators of consciousness that I introduced together with a neuroscientist and another philosopher. Those indicators were originally elaborated targeting animals and AI systems. Our question was: what capacities (deducible from behavior and performance or relevant cerebral underpinnings) make it reasonable to attribute consciousness to these non-human agents? In the same post, I mentioned that we were engaged in a multidisciplinary exploration of the clinical relevance of selected indicators, specifically for testing them on patients with Disorders of Consciousness (DoCs, for instance, Vegetative State/Unresponsive Wakefulness Syndrome, Minimally Conscious State, Cognitive-Motor Dissociation). While this multidisciplinary work is still in progress, we recently published an ethical reflection on the clinical relevance of the indicators of consciousness, taking DoCs as a case study.

To recapitulate, indicators of consciousness are conceived as particular capacities that can be deduced from the behavior or cognitive performance of a subject and that serve as a basis for a reasonable inference about the level of consciousness of the subject in question. Importantly, also the neural correlates of the relevant behavior or cognitive performance may make possible deducing the indicators of consciousness.  This implies the relevance of the indicators to patients with DoCs, who are often unable to behave or to communicate overtly. Responses in the brain can be used to deduce the indicators of consciousness in these patients.

On the basis of this relevance, we illustrate how the different indicators of consciousness might be applied to patients with DoCs with the final goal of contributing to improve the assessment of their residual conscious activity. In fact, a still astonishing rate of misdiagnosis affects this clinical population. It is estimated that up to 40 % of patients with DoCs are wrongly diagnosed as being in Vegetative State/Unresponsive Wakefulness Syndrome, while they are actually in a Minimally Conscious State. The difference of these diagnoses is not minimal, since they have importantly different prognostic implications, which raises a huge ethical problem.

We also argue for the need to recognize and explore the specific quality of the consciousness possibly retained by patients with DoCs. Because of the devastating damages of their brain, it is likely that their residual consciousness is very different from that of healthy subjects, usually assumed as a reference standard in diagnostic classification. To illustrate, while consciousness in healthy subjects is characterized by several distinct sensory modalities (for example, seeing, hearing and smelling), it is possible that in patients with DoCs, conscious contents (if any) are very limited in sensory modalities. These limitations may be evaluated based on the extent of the brain damage and on the patients’ residual behaviors (for instance, sniffing for smelling). Also, consciousness in healthy subjects is characterized by both dynamics and stability: it includes both dynamic changes and short-term stabilization of contents. Again, in the case of patients with DoCs, it is likely that their residual consciousness is very unstable and flickering, without any capacity for stabilization. If we approach patients with DoCs without acknowledging that consciousness is like a spectrum that accommodates different possible shapes and grades, we exclude a priori the possibility of recognizing the peculiarity of consciousness possibly retained by these patients.

The indicators of consciousness we introduced offer a potential help to identify the specific conscious abilities of these patients. While in this paper we argue for the rationale behind the clinical use of these indicators, and for their relevance to patients with DoCs, we also acknowledge that they open up new lines of research with concrete application to patients with DoCs. As already mentioned, this more applied work is in progress and we are confident of being able to present relevant results in the weeks to come.

Written by…

Michele Farisco, Postdoc Researcher at Centre for Research Ethics & Bioethics, working in the EU Flagship Human Brain Project.

Farisco, M., Pennartz, C., Annen, J. et al. Indicators and criteria of consciousness: ethical implications for the care of behaviourally unresponsive patients. BMC Med Ethics 2330 (2022). https://doi.org/10.1186/s12910-022-00770-3

We have a clinical perspective

Can consumers help counteract antimicrobial resistance?

Antimicrobial resistance (AMR) occurs when microorganisms (bacteria and viruses, etc.) survive treatments with antimicrobial drugs, such as antibiotics. However, the problem is not only caused by unwise use of such drugs on humans. Such drugs are also used on a large scale in animals in food production, which is a significant cause of AMR.

In an article in the journal Frontiers in Sustainable Food Systems, Mirko Ancillotti and three co-authors discuss the possibility that food consumers can contribute to counteracting AMR. This is a specific possibility that they argue is often overlooked when addressing the general public.

A difficulty that arises when AMR needs to be handled by several actors, such as authorities, food producers, consumers and retailers, is that the actors transfer the responsibility to the others. Consumers can claim that they would buy antibiotic-smart goods if they were offered in stores, while retailers can claim that they would sell such goods if consumers demanded them. Both parties can also blame how, for example, the market or legislation governs them. Another problem is that if one actor, for example the authorities, takes great responsibility, other actors feel less or no responsibility.

The authors of the article propose that one way out of the difficulty could be to influence consumers to take individual responsibility for AMR. Mirko Ancillotti has previously found evidence that people care about antibiotic resistance. Perhaps a combination of social pressure and empowerment could engage consumers to individually act more wisely from an AMR perspective?

The authors make comparisons with the climate movement and suggest digital innovations in stores and online, which can inform, exert pressure and support AMR-smarter food choices. One example could be apps that help consumers see their purchasing pattern, suggest product alternatives, and inform about what is gained from an AMR perspective by choosing the alternative.

Read the article with its constructive proposal to engage consumers against antimicrobial resistance: The Status Quo Problem and the Role of Consumers Against Antimicrobial Resistance.

Pär Segerdahl

Written by…

Pär Segerdahl, Associate Professor at the Centre for Research Ethics & Bioethics and editor of the Ethics Blog.

Ancillotti, Mirko; Nilsson, Elin; Nordvall, Anna-Carin; Oljans, Emma. The Status Quo Problem and the Role of Consumers Against Antimicrobial Resistance. Frontiers in Sustainable Food Systems, 2022.

This post in Swedish

Approaching future issues